Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07822087) titled 'A Phase 1 Study of ATORM-C in Patients With Crohn's Disease' on Sept. 10.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: ORGANOIDSCIENCES LTD.
Condition:
Crohn's Diseases
Crohn's Disease
Intervention:
Biological: Autologous Adult Stem Cell-Derived Intestinal Organoid
Recruitment Status: Recruiting
Phase: Phase 1
Date of First Enrollment: September 2026
Target Sample Size: 18
Countries of Recruitment:
South Korea
To know more, visit https://clinicaltrials.gov/study/...